Angiotensin-converting enzyme inhibitors and risk of age-related macular degeneration in individuals with hypertension.
Journal Information
Full Title: Br J Clin Pharmacol
Abbreviation: Br J Clin Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"COMPETING INTERESTS Drs Adderley, Nirantharakumar and Denniston reported a grant from Action Against Age‐related Macular Degeneration during the conduct of the study. Dr Adderley reported receiving grants from Medical Research Council, National Institute for Health Research and National Institute for Health Research RfPB outside the submitted work. Dr Nirantharakumar reported receiving grants from Medical Research Council, National Institute for Health Research, AstraZeneca, MSD, Boehringer Ingelheim, Vifor, and Health Data Research UK and personal fees from Sanofi outside the submitted work. Dr Denniston reported receiving grant support from Health Data Research UK outside the submitted work. Dr Braithwaite reported receiving salary support from the patient charity Olivia's Vision. No other disclosures were reported."
"This research was funded by Action Against Age‐related Macular Degeneration, Charity numbers 1 170 224 and SC048549."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025